All opioids induce respiratory depression, which is responsible for 47,000 overdose deaths per year in the US. Despite this deadly side-effect, there are no drugs available that can treat severe pain as effectively as opioids. San Diego based Quivive Pharma (‘kee-veev’) is making these products safer by combining existing opioid pain killers with an FDA approved respiratory stimulant via the 505(b)(2) regulatory path. Our mission is to create a new generation of opioid analgesics that are safer as well as abuse deterrent via all routes of administration. Our products are bioequivalent replacements for the many effective, but unsafe and abusable opioids on the market today.